Nadofaragene firadenovec-vncg led to encouraging rates of high-grade recurrence-free survival and overall survival in patients with high-risk, BCG-unresponsive non–muscle invasive bladder cancer with carcinoma in situ with or without papillary tumors.
New Data Show Durable Response Following Treatment with ADSTILADRIN® (nadofaragene firadenovec-vncg) urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.
AUA 2021 Bone Health and Radionuclide Therapy, bone health in CRPC, Advanced prostate cancer AUA/ASTRO/SUO 2020 guideline, phase III ALSYMPCA trial of radium-223, symptomatic skeletal-related event, benefit of radium-223.
AUA 2021: Identification of High-Risk Disease and Initial Management of Biochemical Recurrence urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.